{"id":"W4410821726","doi":"10.1200/jco.2025.43.16_suppl.4503","title":"Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Durvalumab; Urothelial cancer; Bladder cancer; Perioperative; Cancer; Circulating tumor DNA; Urology; Internal medicine; Oncology; Surgery; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000920971,0.0001691165,0.0008186675,0.0001291941,0.00003877254,0.0000181995,0.0002248355,0.0002858202,0.00003060327],"category_scores_gemma":[0.003110684,0.0001381805,0.0001669039,0.000187389,0.0001590324,0.00001112231,0.0001040069,0.0005460214,0.000001249341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002004259,"about_ca_system_score_gemma":0.002964389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001156358,"about_ca_topic_score_gemma":0.004748567,"domain_scores_codex":[0.9975168,0.0003264856,0.001414818,0.0003144429,0.0001617724,0.0002657378],"domain_scores_gemma":[0.9978712,0.0005381907,0.0008165624,0.0001857622,0.000468356,0.0001199636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00379287,0.001484305,0.9273629,0.00003575862,0.000383955,0.0002850598,0.0003296461,0.004396318,0.003332154,0.00008252913,0.001904025,0.0566105],"study_design_scores_gemma":[0.01130995,0.003876278,0.9632782,0.0002285552,0.00007644396,0.000006582379,0.0002107997,0.00008095213,0.0008826473,0.00008439199,0.01976286,0.0002023852],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954555,0.0005249913,0.00004833977,0.001033631,0.0006881877,0.0002459893,0.0000147331,0.00000147704,0.001987132],"genre_scores_gemma":[0.9953893,0.0008939766,0.0005330701,0.002625065,0.0003661349,0.0000161946,0.00000891083,0.00001683207,0.0001504775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05640811,"threshold_uncertainty_score":0.5634839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02825702325365365,"score_gpt":0.372223055485248,"score_spread":0.3439660322315943,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}